| CPP2022-009545 | Mariano Provencio Pulla | | Atocha Romero Alfonso, Alberto Cruz Bermúdez | 2023 | 2026 | STRAGEN-IO: Clinical validation in liquid biopsy of a genetic and epigenetic signature as a prognostic tool for chemo-immunotherapy in lung cancer patients |
| RTC2019-007359-1 | Mariano Provencio Pulla | | Atocha Romero Alfonso, Alberto Cruz Bermudez, Sandra Sanz Moreno, Roberto Serna Blasco, Carlos Garrido Fernandez, Ana Isabel Rodríguez Charte | 2020 | 2024 | DEVELOPMENT OF MOLECULAR MARKERS IN LIQUID BIOPSY FOR LONG-TERM SURVIVAL IN ONCO-IMMUNOTHERAPY |
| RTC-2017-6502-1 | Mariano Provencio Pulla | | | 2018 | 2022 | INmunoSIGHT. Immunological and molecular characterisation in liquid biopsy of lung cancer patients for immunotherapy |
| EpiNanSarc-AC24/00041 | Atocha Romero Alfonso | | Ana San Martín Doblado | 2025 | 2027 | Sarcoma subtyping and stratification using genome-wide epigenetic profiling |
| UNCAN-Connect | Mariano Provencio Pulla | | | 2025 | 2030 | UNCAN-Connect (GA nº101215206). Decentralised Collaborative Network for Advancing Cancer Research and Innovation |
| CLARIFY | Mariano Provencio Pulla | | Constanza Maximiano Alonso, Maria Torrente Regidor, Ana Collazo Lorduy, Erika Cerrolaza Molina, Carlos Garrido Fernandez | 2020 | 2025 | Artificial intelligence follow-up for long-term cancer survivors |
| P4-LUCAT (PERME19002RODR) | Mariano Provencio Pulla | | | 2020 | 2024 | Personalised medicine for lung cancer treatment: using Big Data-driven approaches for decision support |
| BigMedilytics | Mariano Provencio Pulla | | | 2018 | 2022 | BigMedilytics |
| IND2019/BMD-17258 | Atocha Romero Alfonso | | | 2020 | 2023 | Identification of Mechanisms of Resistance to ALK Inhibitors. Next-generation sequencing-based liquid biopsy profiling: A step towards personalised treatment |
| S2017/BMD-3778 LYMPHOMAS | Antonio Carlos Sanchez Ruiz | | | 2018 | 2022 | Aggressive lymphomas, integrated clinical and genomic analysis for precision medicine |
| ICI25/00112 | Mariano Provencio Pulla | | | 2026 | 2027 | Multicentre prospective phase 1 study to evaluate the safety and feasibility of adoptive cell therapy with TILs as salvage treatment for patients with NSCLC and malignant melanoma |
| PI25/00553 | Santiago Barrio Garcia | | Mariola Blanco Clemente | 2026 | 2028 | Development and validation of specific methylation fingerprints for the diagnosis, prognosis and monitoring of response in diffuse large B-cell lymphoma |
| PI25/01704 | Mariano Provencio Pulla | | | 2026 | 2028 | Adjuvant Chemotherapy-Immunotherapy in Resected Lung Cancer: Treatment Personalisation Based on the Tumour Microenvironment and Minimal Residual Disease |
| PI24/01725 | Atocha Romero Alfonso | | | 2025 | 2027 | Role of the gut microbiota in the response to chemo-immunotherapy in non-small cell lung cancer |
| PI23/01054 | Alberto Cruz Bermúdez | | Carlos Garrido Fernández, Ana Isabel Rodríguez Charte, María Belén Sierra Rodero, Mariola Blanco Clemente, Roberto Serna Blasco | 2024 | 2026 | Perioperative chemoimmunotherapy in NSCLC: monitoring antitumour immunity by single-cell analysis to personalise adjuvant treatment |
| CERT22/00070 | Cristina Avendaño Solá | | Mariano Provencio Pulla | 2024 | 2026 | State-Funded Network Consortium for the Development of Advanced Therapy Medicinal Products (CERTERA) |
| PI22/00085 | Ana Laura Sanz Alcober | | Lourdes Gutierrez Sanz | 2023 | 2026 | Generation of autologous colorectal cancer organoids to personalise immunotherapy strategies |
| PI22/01223 | Mariano Provencio Pulla | | Alberto Cruz Bermúdez, Marta Casarrubios García, Roberto Serna Blasco, María Belén Sierra Rodero, Cristina Martínez Toledo, Carlos Garrido Fernández, Ana Isabel Rodríguez Charte | 2023 | 2025 | Chemoimmunotherapy in locally advanced NSCLC: validation of biomarkers derived from ctDNA and the tumour microenvironment |
| PI22/01603 | Virginia Calvo De Juan | | Marta Casarrubios García, María Belén Sierra Rodero, Cristina Martínez Toledo, Lucia Robado De Lope, Mariola Blanco Clemente | 2023 | 2027 | Residential radon and molecular alterations in non-small-cell lung cancer. |
| PI21/01500 | Atocha Romero Alfonso | | Alejandro Rodríguez Festa, Sandra Sanz Moreno, Roberto Serna Blasco, Lucia Robado De Lope | 2022 | 2025 | Biomarkers4Cure: Predictive biomarkers of response to combinations of immunotherapy plus neoadjuvant chemotherapy in patients with operable lung cancer |
| DTS21/00124 | Atocha Romero Alfonso | | Alejandro Rodríguez Festa, Sandra Sanz Moreno, Lucia Robado De Lope | 2022 | 2024 | CLINICAL VALIDATION OF A SYSTEM FOR DETECTING ALK TRANSLOCATIONS IN EXTRACELLULAR VESICLES IN PLASMA III |
| PI20/00320 | Fernando Domínguez Rodríguez | | Clara Salas Antón | 2021 | 2025 | Prevalence and prognostic implications of inflammation in dilated cardiomyopathy: utility of 18-FDG PET-CT |
| PI19/01652 | Mariano Provencio Pulla | | María Torrente Regidor, Raquel Laza Briviesca, Alberto Cruz Bermúdez, Marta Casarrubios García | 2020 | 2024 | Tumour immune microenvironment and identification of biomarkers of response to neoadjuvant chemotherapy or chemoimmunotherapy in patients with non-small-cell lung cancer |
| P4-LUCAT - AC19/00026 | Mariano Provencio Pulla | | Maria Torrente Regidor | 2020 | 2023 | Personalised medicine for lung cancer treatment: using Big Data-driven approaches for decision support |
| PI19/00132 | Ana Laura Sanz Alcober | | Gutierrez Sanz, Lourdes | 2020 | 2022 | Resistance to immunotherapy in colorectal cancer: role of the tumour microenvironment and strategies to reverse it |
| PI18/01778 | Jose Miguel Garcia Ruiz | | Calvo De Juan, Virginia; Cruz Bermudez, Alberto; Garcia Grande, Aranzazu; Gutierrez Sanz, Lourdes; Laza Briviesca, Raquel; Sanchez Herrero, Estela | 2019 | 2023 | Predictive value of CB2 expression for treatment response in colon cancer |
| PI17/01977 | Atocha Romero Alfonso | | | 2018 | 2021 | Clinical utility of liquid biopsy in patients with non-small-cell lung cancer with EML4-ALK translocation |
| AC24/00041 | Atocha Romero Alfonso | | | | | Sarcoma subtyping and stratification using genome-wide epigenetic profiling |
| Ministry for Digital Transformation | TSI-100123-2024-3 (SHARE) | Mariano Provencio Pulla | | | 2025 | 2026 | SHARE: Spanish cAnceR data spacE |
